awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26771870-627341F9-847F-4D0D-956D-38EAF1E36086
Q26771870-627341F9-847F-4D0D-956D-38EAF1E36086
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26771870-627341F9-847F-4D0D-956D-38EAF1E36086
Predictors of clinical response to immunotherapy with or without radiotherapy
P2860
Q26771870-627341F9-847F-4D0D-956D-38EAF1E36086
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26771870-627341F9-847F-4D0D-956D-38EAF1E36086
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4b9c2b91e84f6b6da5b2ede438c84b55ebfdc73b
P2860
Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial